
Alteplase (rtPA)
Alteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction and PE

Alteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction and PE

Oculocephalic and oculovestibular reflexes are primarily used to determine whether a patient's brainstem is intact (e.g. coma or brain death assessment)

Hearing Loss in ICU is an under-appreciated problem: Conductive (external ear; middle and inner ear; Sensorineural)

HSV Encephalitis: severe viral infection of the central nervous system, caused by a herpes simplex virus and usually localised to the temporal and frontal lobe; most commonly identified cause of infectious encephalitis; 5-10% of encephalitis cases worldwide

Hypoxic Brain Injury: in adults, typically occurs after cardiac arrest, trauma or drug overdose; degree of injury proportional to duration and severity of oxygen deprivation to the brain

Myasthenia Gravis: autoimmune disruption of post-synaptic acetylcholine receptors at NMJ; up to 80% of functional receptors loss; typically young woman; may have thymus hyperplasia; prevalence = 14.2 cases per 100,000

Myopathy versus Neuropathy

Neurology Literature Summaries

Non-Convulsive Status Epilepticus (NCSE) is a persistent change in the level of consciousness, behaviour, autonomic function, and sensorium from baseline associated with continuous epileptiform EEG changes, but without major motor signs

Intracardiac Masses Echocardiography

Continuous renal replacement therapy (CRRT) is the modality most widely used in Australia and New Zealand ICUs. There is no evidence suggesting mortality benefit for one modality over another

Highlights and pearls on toxic alcohol ingestion from the EBMedicine article, "Toxic Alcohols: Not Always A Clear-Cut Diagnosis"